Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.
about
Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Flibanserin (Addyi): The First ...... sorder in Premenopausal Women.
@en
Flibanserin
@nl
type
label
Flibanserin (Addyi): The First ...... sorder in Premenopausal Women.
@en
Flibanserin
@nl
prefLabel
Flibanserin (Addyi): The First ...... sorder in Premenopausal Women.
@en
Flibanserin
@nl
P2093
P2860
P1476
Flibanserin (Addyi): The First ...... sorder in Premenopausal Women.
@en
P2093
Anne Muhleisen
Clayton English
Jose A Rey
P2860
P304
P577
2017-04-01T00:00:00Z